14 results
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
Dosing TDD in ... (stage IV or V CKD ... #Insulin #dosing ... #pharmacology #endocrinology ... #diabetes #DM2
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... Improved outcomes in CKD ... comparison #management #endocrinology ... #dm2
The “twin cycles” of diabetes, first introduced by Roy Taylor in 2008.  
#fatty liver #fatty
twin cycles” of diabetes ... fatty pancreas #diabetes ... #t2d #dm2 #insulin ... pathophysiology #endocrinology
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
cells, triggering insulin ... contraindicated in CKD ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
patients with T2D ... mL/minute/1.73 m2 ... diabetic ketoacidosis ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Sulfonylurea, TZD ... in Type 1 Diabetes ... #Mellitus #DM2 ... comparison #table #endocrinology
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
patients with T2D ... ml/min per 1.73 m2 ... intermediate targets for glycemia ... #Diabetes #CKD # ... #KDIGO #eGFR #Insulin
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
glucose-dependent insulin ... patients with T2D ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
Insulin Calculations for Type 1 Diabetes 

Insulin-to-Carb Ratio (ICR) 500/TDD = #g of carbs covered by
for Type 1 Diabetes ... Ratio (ICR) 500/TDD ... calculations used in dosing ... #DM1 #Pharmacology ... #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... -> Stimulates Insulin ... will stimulate insulin ... Pharmacology #Management #Diabetes ... #DM2 #Endocrinology